Adult Vaccination Policy: Gaps, Hesitancy, and Reform
This paper examines the current state of adult vaccination and immunization policy in the United States, where vaccine-preventable diseases continue to cause tens of thousands of deaths and hundreds of thousands of hospitalizations annually. The paper reviews existing federal and state vaccination policies—particularly the Affordable Care Act—and identifies critical gaps in their financial frameworks, implementation, and public outreach. It analyzes the causes of persistent low adult vaccination coverage, including physician dissatisfaction, access barriers, and widespread vaccine hesitancy fueled by misinformation. The paper concludes by proposing a new public health policy framework centered on public education, routine clinical assessment of vaccination status, and expanded vaccine availability through pharmacies and workplaces.
- Introduction: The Case for Adult Vaccination Policy: Low adult vaccination rates and policy need
- Current Federal and State Vaccination Policies: Overview of ACA and state vaccination laws
- Gaps and Failures in the Affordable Care Act: ACA's financial and implementation shortcomings
- Vaccine Hesitancy and Its Policy Roots: How policy gaps fuel hesitancy and misinformation
- Proposed Policy Reforms to Improve Adult Vaccination: Education, clinical assessment, and expanded access proposals
- Immunization Information Systems and Evaluation: Tracking outcomes through data and collaboration
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper grounds its policy argument in concrete epidemiological data—citing CDC hospitalization estimates and cost figures—giving its claims measurable weight rather than relying solely on abstract assertions.
- It moves logically from describing the problem (low coverage, deaths) to diagnosing the cause (policy gaps) to proposing solutions, creating a clear problem–cause–solution arc that is easy to follow.
- The paper balances multiple stakeholder perspectives—patients, physicians, policymakers, and public health agencies—showing how gaps in a single federal law ripple outward to affect each group differently.
Key academic technique demonstrated
The paper demonstrates effective policy analysis by first establishing a baseline (what existing law requires), then systematically identifying unintended consequences and implementation failures (physician dissatisfaction, financial loopholes, access barriers), and finally deriving targeted reform proposals directly from the diagnosed gaps. This ensures that each recommendation is traceable back to documented evidence rather than appearing as a generalized wish list.
Structure breakdown
The paper opens with an epidemiological overview establishing urgency, then surveys existing federal and state vaccination laws. The central section critiques the Affordable Care Act's financial framework and documents its unexpected outcomes for both providers and patients. A dedicated section connects these policy failures to vaccine hesitancy. The closing sections propose three concrete policy reforms—education, routine clinical assessment, and expanded access—and call for an immunization information system to track outcomes. References follow APA format throughout.
Introduction: The Case for Adult Vaccination Policy
Vaccines and immunizations are critical components of routine healthcare for children and adults in the United States. They offer protection against vaccine-preventable diseases and help prevent severe illness, disability, and death. Despite their importance, between 50,000 and 90,000 adults die annually from vaccine-preventable diseases, and the rate of hospitalizations from these diseases has increased tremendously since 2010. For instance, the CDC estimates that influenza has contributed to between 140,000 and 810,000 hospitalizations each year since 2010 (Lu et al., 2021). Based on all age-appropriate vaccination data across age groups, vaccination and immunization rates remain significantly low. New public health policy that incorporates education and publicity, routine evaluation of vaccinations, and increased availability of vaccines would significantly improve adult vaccination coverage and reduce deaths from vaccine-preventable diseases.
Vaccines and immunizations are major achievements of modern medicine that have made enormous contributions to saving millions of lives across the globe. Vaccinations are one of the few public health measures with significant impact on disease prevention, as they have substantially lessened disease, disability, and death from several infectious diseases (Orenstein & Ahmed, 2017). As noted by Nandi & Shet (2020), vaccines and immunizations have reduced the spread and effect of infectious diseases by over 90%. Childhood vaccinations save approximately 2–3 million lives across the globe annually and have contributed to a reduction in the global infant mortality rate from 65 to 29 per 1,000 live births between 1990 and 2018. The Centers for Disease Control and Prevention (2020) reports that vaccines have helped effectively control and/or eradicate polio, tetanus, influenza, rubella, measles, Haemophilus influenzae type b (Hib), Hepatitis A, Hepatitis B, pneumococcal disease, mumps, rotavirus, whooping cough, diphtheria, and chickenpox.
Vaccine-preventable hospitalizations and deaths remain a major public health concern. The National Vaccine Program Office (2020) reports that adult vaccination rates in the United States remain significantly below the Healthy People 2020 targets. While safe and effective vaccines with a solid track record are available, many adults do not stay up-to-date with their vaccinations and immunizations. The rate of vaccine hesitancy among adults appears to increase with age. It is estimated that the health and productivity costs of vaccine-preventable diseases such as influenza total approximately $87 billion annually. According to the CDC, nearly 40,000 cases and 4,000 deaths among adults are caused by invasive pneumococcal disease each year—a condition that is entirely vaccine-preventable (The National Vaccine Program Office, 2020).
Most adults in the United States remain unprotected against diseases that could be prevented by vaccines. The CDC reports that few adults aged 19 years or older have received age-appropriate vaccines, which is an indicator of low vaccination coverage in this population (Lu et al., 2021). It is estimated that between 20.1% and 87.5% of U.S. adults have not received recommended vaccinations, either for all individuals or those with specific conditions (Lu et al., 2021). While modest gains occurred for hepatitis B and HPV adult vaccinations between 2017 and 2018, individual adult vaccination coverage across the country remains low, and coverage for other diseases did not improve during the same period. Given the aging of the U.S. population, the percentage of adults unprotected against vaccine-preventable diseases is expected to grow, increasing the healthcare burden these diseases impose.
Create your account
Always verify citation format against your institution’s current style guide requirements.